Drug resistance mutations of hepatitis B virus (HBV) influence the yield of the virions of the human hepatitis delta virus (HDV) and their infectivity. [PDF]
Chazova O, Zaiets I, Gudima SO.
europepmc +1 more source
Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta. [PDF]
Oberhardt V +22 more
europepmc +1 more source
Integrated Diagnosis of Hepatitis B, C, and D Viruses and HIV in Populations Evaluated for Sexually Transmitted Infections: A Narrative Review and Operational Framework. [PDF]
Cabezas J +12 more
europepmc +1 more source
FDA approval of hepcludex: a milestone in the treatment of chronic hepatitis delta virus infection. [PDF]
Fatima E, Oduoye MO.
europepmc +1 more source
Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes. [PDF]
Vasilev P +8 more
europepmc +1 more source
Combination therapeutics for hepatitis delta virus infection: implications of the tobevibart-elebsiran SOLSTICE phase 2 trial. [PDF]
Block PD, Lim JK.
europepmc +1 more source
National HBsAb serosurvey and HBsAg/Hepatitis D coinfection prevalence across sociodemographic and immigrant populations in Israel. [PDF]
Yael G +6 more
europepmc +1 more source
Improvement in the Microbiological Diagnosis of Hepatitis D on the Mediterranean Coast of Southeastern Spain: A Repeated Cross-Sectional Survey. [PDF]
Ventero MP +27 more
europepmc +1 more source
Comprehensive Analysis of Mutations in the Hepatitis Delta Virus Genome Based on Full-Length Sequencing in Individuals Infected with Genotype 3 in Brazil. [PDF]
Roca TP +8 more
europepmc +1 more source
Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. [PDF]
Matar R +10 more
europepmc +1 more source

